Evidence map›Paper›PMID 36982952›Full record

ArticleInternational journal of molecular sciences2023

LINC01393, a Novel Long Non-Coding RNA, Promotes the Cell Proliferation, Migration and Invasion through MiR-128-3p/NUSAP1 Axis in Glioblastoma.

Deheng Li, Junda Hu, Sen Li, Changshuai Zhou, Mingtao Feng, Liangdong Li, Yang Gao, Xin Chen, Xiaojun Wu, Yiqun Cao and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. The role and therapeutic value of NUSAP1 in human cancers.Journal of translational medicine · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Deheng LiDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Junda HuDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Sen LiDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Changshuai ZhouDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.ORCID 0000-0003-3708-6146
Mingtao FengDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Liangdong LiDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Yang GaoDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Xin ChenDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Xiaojun WuDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Yiqun CaoDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Bin HaoDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Lei ChenDepartment of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.ORCID 0000-0002-4726-7293
Shanghai Medical College of Fudan University · CN

Funding

National Cancer Center Climbing Program of China NCC201809B028
6 · The paper itself

Abstract

Nucleolar and spindle-associated protein 1 (NUSAP1) is a potential molecular marker and intervention target for glioblastoma (GBM). In this study, we aim to investigate upstream regulatory lncRNAs and miRNAs of NUSAP1 through both experimental and bioinformatic methods. We screened upstream lncRNAs and miRNAs of NUSAP1 through multiple databases based on ceRNA theory. Then, in vitro and in vivo experiments were performed to elucidate the relevant biological significance and regulatory mechanism among them. Finally, the potential downstream mechanism was discussed. LINC01393 and miR-128-3p were screened as upstream regulatory molecules of NUSAP1 by TCGA and ENCORI databases. The negative correlations among them were confirmed in clinical specimens. Biochemical studies revealed that overexpression or knockdown of LINC01393 respectively enhanced or inhibited malignant phenotype of GBM cells. MiR-128-3p inhibitor reversed LINC01393 knockdown-mediated impacts on GBM cells. Then, dual-luciferase reporter assay and RNA immunoprecipitation assay were conducted to validate LINC01393/miR-128-3p/NUSAP1 interactions. In vivo, LINC01393-knockdown decreased tumor growth and improved mice survival, while restoration of NUSAP1 partially reversed these effects. Additionally, enrichment analysis and western blot revealed that the roles of LINC01393 and NUSAP1 in GBM progression were associated with NF-κB activation. Our findings showed that LINC01393 sponged miR-128-3p to upregulate NUSAP1, thereby promoting GBM development and progression via activating NF-κB pathway. This work deepens understanding of GBM mechanisms and provides potential novel therapeutic targets for GBM.

Indexed as

Brain NeoplasmsGlioblastomaMicroRNAsRNA, Long NoncodingAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticMiceMicrotubule-Associated ProteinsNF-kappa BMicroRNAsMicrotubule-Associated ProteinsNF-kappa BRNA, Long Noncodingcompeting endogenous RNAglioblastomaLINC01393miR-128-3pnucleolar and spindle-associated protein 1

Identifiers

PMID36982952
PMCPMC10056594
OpenAlexW4327953188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.